文献速递慢阻肺间质性肺疾病肺结节与肺癌

低剂量CT肺癌筛查中的偶发呼吸病发现与呼吸病死亡相关

Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases.
PubMed 文献 · Chest · 2021-11-25

本研究基于NLST低剂量CT筛查组数据,分析偶发呼吸病相关发现与呼吸病死亡(RDM)的关系。结果显示肺气肿和网状影与RDM风险升高相关,且不同COPD病史人群的10年累积RDM存在差异。

要点

  • 肺气肿和网状影是LDCT筛查中常见的偶发发现,与呼吸病死亡风险升高相关。
  • 无COPD病史者中,同时有肺气肿和网状影者10年累积RDM为3.9%,均无者为1.1%。
  • 有COPD病史者中,同时有肺气肿和网状影者10年累积RDM为17.3%,均无者为3.7%。

核心结论

  • NLST低剂量CT筛查中偶发呼吸病相关发现频繁,且与呼吸病死亡风险增加相关。

研究设计与样本

  • 分析NLST低剂量CT筛查组数据,共26,722名受试者,其中25,002名接受基线及后续LDCT筛查。
  • 采用Kaplan-Meier曲线评估累积呼吸病死亡率,多变量比例风险模型评估风险因素。
  • 中位死亡随访时间为10.3年。

主要发现

  • 基线LDCT肺气肿检出率为30.7%,任一次筛查为44.2%。
  • 基线LDCT有肺气肿者中,18%报告有COPD/肺气肿病史。
  • 共3,639例死亡,其中708例死于呼吸系统疾病。
  • 多变量模型中,LDCT肺气肿与RDM风险显著升高相关(HR 2.27;95% CI 1.92-2.7)。
  • 网状影(包括蜂窝状/纤维化/瘢痕)与RDM风险显著升高相关(HR 1.39;95% CI 1.19-1.62)。

关键数值与推荐

  • 无COPD/肺气肿病史者中,同时有肺气肿和网状影者10年累积RDM为3.9%,均无者为1.1%。
  • 有COPD/肺气肿病史者中,同时有肺气肿和网状影者10年累积RDM为17.3%,均无者为3.7%。

临床怎么用

  • LDCT筛查中发现的肺气肿和网状影应引起临床关注,可能提示呼吸病死亡风险升高。
  • 对于有COPD/肺气肿病史且LDCT显示肺气肿和网状影者,10年累积RDM较高,需加强管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Incidental respiratory disease-related findings are frequently observed on low-dose CT (LDCT) lung cancer screenings. This study analyzed data from the National Lung Screening Trial (NLST) to assess the relationship between such findings and respiratory disease mortality (RDM), excluding lung cancer. RESEARCH QUESTION: Are incidental respiratory findings on LDCT scanning associated with increased RDM? STUDY DESIGN AND METHODS: Subjects in the NLST LDCT arm received three annual screens. Trial radiologists noted findings related to possible lung cancer, as well as respiratory-related incidental findings. Demographic characteristics, smoking history, and medical history were captured in a baseline questionnaire. Kaplan-Meier curves were used to assess cumulative RDM. Multivariate proportional hazards models were used to assess risk factors for RDM; in addition to incidental CT scan findings, variables included respiratory disease history (COPD/emphysema, and asthma), smoking history, and demographic factors (age, race, sex, and BMI). RESULTS: Of 26,722 subjects in the NLST LDCT arm, 25,002 received the baseline screen and a subsequent LDCT screen. Overall, 59% were male, 26.5% were aged ≥ 65 years at baseline, and 10.6% reported a history of COPD/emphysema. Emphysema on LDCT scanning was reported in 30.7% of subjects at baseline and in 44.2% at any screen. Of those with emphysema on baseline LDCT scanning, 18% reported a history of COPD/emphysema. Median mortality follow-up was 10.3 years. There were 3,639 deaths, and 708 were from respiratory diseases. Among subjects with no history of COPD/emphysema, 10-year cumulative RDM ranged from 3.9% for subjects with emphysema and reticular opacities to 1.1% for those with neither condition; the corresponding range among subjects with a COPD/emphysema history was 17.3% (both) to 3.7% (neither). Emphysema on LDCT imaging was associated with a significantly elevated RDM hazard ratio (2.27; 95% CI, 1.92-2.7) in the multivariate model. Reticular opacities (including honeycombing/fibrosis/scar) also had a significantly elevated hazard ratio (1.39; 95% CI, 1.19-1.62). INTERPRETATION: Incidental respiratory disease-related findings observed on NLST LDCT screens were frequent and associated with increased mortality from respiratory diseases.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Pinsky PF, Lynch DA, Gierada DS, et al. Incidental Findings on Low-Dose CT Scan Lung Cancer Screenings and Deaths From Respiratory Diseases. Chest. 2021. PMID: 34838524. doi:10.1016/j.chest.2021.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。